Understanding Life on GLP-1s
Omnia Health Solutions is focused on understanding the real-world experiences of individuals using GLP-1 medications over time. Our flagship platform, BEACON, combines IRB-approved longitudinal research and patient engagement to generate ongoing insight into treatment persistence, quality of life, behavioral trends, and the evolving experience of GLP-1 care.
Now Enrolling: The Study
A decentralized, longitudinal study focused on understanding life on GLP-1 medications
Omnia's network is driven by both patients and primary care teams.
This model is powering The BEACON Study, our flagship effort to track and understand long-term GLP-1 outcomes.
With an IRB-approved protocol,
we capture longitudinal data on adherence, outcomes, and patient experiences over months and years—not just weeks.
"Obesity care is evolving rapidly, and we need solutions that bridge the gap between clinical research and everyday practice. Omnia is uniquely positioned to close that gap, ensuring that innovation reaches the patients who need it most."
– Dr. Holly Lofton, Director of the Medical Weight Management Program at NYU Langone Health
Omnia doesn’t just track outcomes. We improve them.
Through ongoing engagement and longitudinal research, BEACON helps participants better understand their treatment journey while contributing to deeper insight into the long-term experience of GLP-1 care.
